p16(INK4a) status and survival benefit of EGFR inhibitors in head and neck squamous cell cancer: A systematic review and meta-analysis | |
Su, Yapin; Cu, Jiuwei; Xu, Dongsheng; Wang, Mengmeng; Xu, Tiankai; Tian, Huimn; Han, Fujun | |
刊名 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY |
2018 | |
卷号 | 124 |
关键词 | Epidermal growth factor receptor Head and neck Human papilloma virus Meta-analysis p16 |
ISSN号 | 1040-8428 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3535407 |
专题 | 吉林大学白求恩第一医院 |
推荐引用方式 GB/T 7714 | Su, Yapin,Cu, Jiuwei,Xu, Dongsheng,et al. p16(INK4a) status and survival benefit of EGFR inhibitors in head and neck squamous cell cancer: A systematic review and meta-analysis[J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY,2018,124. |
APA | Su, Yapin.,Cu, Jiuwei.,Xu, Dongsheng.,Wang, Mengmeng.,Xu, Tiankai.,...&Han, Fujun.(2018).p16(INK4a) status and survival benefit of EGFR inhibitors in head and neck squamous cell cancer: A systematic review and meta-analysis.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY,124. |
MLA | Su, Yapin,et al."p16(INK4a) status and survival benefit of EGFR inhibitors in head and neck squamous cell cancer: A systematic review and meta-analysis".CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 124(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论